Ann: Notice of Annual General Meeting/Proxy Form , page-106

re: Ann: Notice of Annual General Meeting/Pro... If it turns out to be a CR to fund it's own product I expect that will be a costly failure. I fully expect OBJ tech to get commercialised one day, but wasting shareholder funds to get an OBJ own product into the market in a futile attempt to bluff the FMCG's is stupidity.

Holders need to vote against all 3 resolutions at the AGM to tell mgt of their concern against this.

OBJ mgt need to take a leaf of long term holders books and try a little patience. If surges scenario plays out there remains short term risk for OBJ.

It would be a tragedy to not commercialise this science, unfortunately OBJ are starting to appear that they haven't the expertise to do it properly.

bluebush